BiotechTube
Home/T3 Pharmaceuticals/Dr. Simon J. Ittig
DS

Dr. Simon J. Ittig

Chief Executive Officer

T3 Pharmaceuticals

Therapeutic Areas

Oncology

T3 Pharmaceuticals Pipeline

DrugIndicationPhase
T3P-Y058-1Solid TumorsPre-clinical

Leadership Team at T3 Pharmaceuticals

DC
Dr. Christoph A. Kasper
Chief Scientific Officer
PD
Prof. Dr. med. Gerd Munzert
Chief Medical Officer
DW
Daniel Weber
Chairman of the Board
View full T3 Pharmaceuticals profile